There has been a dramatic increase in the number and type of procedures performed in the field of cardiac intervention in the past decade. Percutaneous intervention is becoming an increasingly recognized modality for the management of prosthetic paravalvular leakages (PVLs) in severely symptomatic non-surgical candidates. Herein, we report our experience of percutaneous closure using the Amplat...

Ventricular septal defect concurrent with left ventricular aneurysm is unusual in postinfarction patients. The complex anatomy is challenging for occluder deployment in transcatheter closure and associated with high risk of aneurysm perforation. We present a case of transcatheter closure of a large postinfarction ventricular septal defect with an Amplatzer septal occluder in a 71-year-old woman...

The Amplatzer duct occluder (ADO) (AGA Medical Corp., Golden Valley, MN) is designed to meet criteria for an optimal transcatheter technique for closure of a patent ductus arteriosus. It was developed as an alternative to surgical closure and other interventional techniques. It is not technically complex, allows controlled deployment, is retrievable and repositionable, and has a low risk of emb...

We report the first use of bilateral femoral venovenous rail creation for the delivery of an Amplatzer Muscular Ventricular Septal Defect Occluder in a patient with a large mid-to-apical muscular ventricular septal defect before Rastelli operation. The presence of a right-sided bidirectional Glenn shunt, a banded main pulmonary artery, and double outlet right ventricle anatomy precluded the use...

Patent ductus arteriosus (PDA) is a congenital heart disease that frequently escapes detection until the patient reaches adulthood. Percutaneous closure of the PDA has been established as a safe alternative to surgery, the Amplatzer duct occluder (ADO) is a new device that has been recently reported in paediatric patients. Our initial experience with an of ADO in an adult population appears to ...

Manuscript received November 18, 2014; accepted November 22, 2014. Coils and Amplatzer plugs (St. Jude Medical, St. Paul, Minnesota) have been used to achieve closure in congenital fistulae (2,3); however, in the much larger diameter iatrogenic fistulae there has been 1 case described in which covered stents were used for closure (4). We describe a case of a large left anterior descending fistu...

A 70-year-old male patient was referred for closure of patent foramen ovale after recurrent transient cerebral ischaemia. A 25-mm Amplatzer PFO occluder was implanted. Thereafter and due to his age and a history of chest pain during the past six months, we performed coronary angiograms which demonstrated tight stenosis of the distal part and significant stenosis of the proximal part of the righ...

Lepidic predominant adenocarcinoma (LPA) (formerly known as bronchioalveolar carcinoma) has rarely been reported to cause refractory hypoxia with intrapulmonary shunting [1-7]. We describe a case who underwent the palliative strategy of intravascular right lower pulmonary artery embolisation with an 18 mm Amplatzer II vascular plug to reduce intrapulmonary shunting. This is the first report we ...

A 68 year old woman presented with right ventricular myocardial infarction complicated by refractory hypoxaemia. She was found to have a significant right to left shunt at the atrial level through a previously undiagnosed ostium secundum atrial septal defect. Percutaneous closure of the atrial septal defect with an Amplatzer septal occluder resulted in prompt improvement in her oxygenation and ...

Atrial septal defect (ASD) is second common congenital heart disease that often leads to adult period. Intracardiac or transesophageal echocardiography (TEE) is essential for percutaneous closure of ASD using Amplatzer septal occluder. Dexmedetomidine (DEX), which is a highly selective α2-agonist, has sedative and analgesic properties without respiratory depression in the clinical dose range. W...